Jun 30, 2022

VIRALEZE™ relaunched by LloydsPharmacy in the UK (ASX Announcement)

VIRALEZE™ relaunched by LloydsPharmacy in the UK (ASX Announcement)
  • VIRALEZE™ has overnight been relaunched in the UK through LloydsPharmacy Online, with distribution to pharmacies to follow shortly
  • LloydsPharmacy is one of the largest pharmacy chains in the UK with ~1,400 stores, and through its affiliated wholesale arm, AAH, also supplies over 14,000 independent UK pharmacies

Melbourne, Australia; 30 June 2022: Starpharma (ASX: SPL, OTCQX: SPHRY) today announced that VIRALEZE™ nasal spray has been relaunched by LloydsPharmacy in the UK. Product has already been delivered to LloydsPharmacy’s distribution centre.

LloydsPharmacy is one of the largest pharmacy groups in the UK, and its affiliated wholesale arm, AAH, is also one of the largest pharmaceutical wholesalers in the UK, supplying over 14,000 independent UK pharmacies.

In the UK, Starpharma will supply VIRALEZE™ exclusively to LloydsPharmacy/AAH under its existing sales and distribution agreement. LloydsPharmacy has approximately 1,400 UK pharmacies, based predominantly in community and health centre locations, including over 200 pharmacies in Sainsbury stores. The group employs more than 19,000 people and dispenses more than 150 million prescription items annually.

Dr Jackie Fairley, the CEO of Starpharma, said:

“We are delighted to relaunch Starpharma’s innovative nasal spray, VIRALEZE™, in the UK through LloydsPharmacy’s extensive online and retail network. VIRALEZE™ will be particularly useful in the winter cold and flu season given its broad-spectrum of activity against multiple cold and respiratory viruses. VIRALEZE™ is supported by multiple publications in peer-reviewed, international journals and was presented at leading, international antiviral conference, CROI, earlier this year.”

VIRALEZE™ is registered in more than 30 countries, including the UK, and Starpharma continues to pursue registration and commercialisation in multiple other countries.

 

LloydsPharmacy

The LloydsPharmacy group incorporates a number of market leading UK healthcare businesses across retail, digital, homecare and wholesale, including LloydsPharmacy, John Bell & Croyden and wholesaler, AAH Pharmaceuticals.  LloydsPharmacy has around 1,400 pharmacies across the UK. These are based predominantly in community and health centre locations and include over 200 LloydsPharmacy in Sainsbury’s stores. The group employs over 19,000 employees and dispenses more than 150 million prescription items annually. 

AAH is a leading distributor of pharmaceutical and healthcare products serving pharmacies, hospitals and doctors in the UK. AAH is the largest community pharmacy network and pharmaceutical wholesaler delivering over 15 million items per week to more than 14,000 pharmacies and other organisations.

VIRALEZE Nasal Spray

VIRALEZE™ is a nasal spray that physically traps and blocks cold/respiratory viruses in the nasal cavity. VIRALEZE™ is applied in the nose where it forms a physical moisture barrier between viruses and the nasal mucous membrane that traps and blocks virus.

VIRALEZE™ is registered as a medical device in more than 30 countries and is available in certain markets online. Product claims may differ by market. Starpharma markets VIRALEZE™ via commercial arrangements in countries in Europe, Asia, and the Middle East.

VIRALEZE™ was developed with the support of $1 million in funding by the Australian Government’s Medical Research Future Fund (MRFF) Biomedical Translation Bridge (BTB) Program, with support from UniQuest.

VIRALEZE™ is not approved for sale or supply in Australia.

 

Download full announcement here: VIRALEZE™ relaunched by LloydsPharmacy in the UK (PDF 193KB)

 This contains certain forward-looking statements.